--- type: "Topics" locale: "en" url: "https://longbridge.com/en/topics/100000000606239.md" description: "$Viking Therap(VKTX.US) | ๐•๐ข๐ค๐ข๐ง๐  ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ: Raymond James reiterates ๐’๐ญ๐ซ๐จ๐ง๐  ๐๐ฎ๐ฒ, maintains ๐๐“ ๐š๐ญ $๐Ÿ๐Ÿ๐Ÿ–Analyst sees GLP-1/GIP data readthrough as neutral-to-positive, with no meaningful LBM disadvantage and stronger weight loss profile supporting VKTX outlook.Source: Hardik Shah" datetime: "2026-04-24T10:47:36.000Z" locales: - [en](https://longbridge.com/en/topics/100000000606239.md) - [zh-CN](https://longbridge.com/zh-CN/topics/100000000606239.md) - [zh-HK](https://longbridge.com/zh-HK/topics/100000000606239.md) author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)" generator: "portal-rs" --- # $Viking Therap(VKTX.US) | ๐•๐ข๐ค๐ข๐ง๐  ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ: Rayโ€ฆ ### Related Stocks - [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md) - [RJF.US](https://longbridge.com/en/quote/RJF.US.md) - [RJF-B.US](https://longbridge.com/en/quote/RJF-B.US.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**